Revolution Medicines (RVMD)
(Delayed Data from NSDQ)
$46.44 USD
+0.88 (1.93%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $46.40 -0.04 (-0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/13/2024
Time: -- |
6/2024 | $-0.77 | -1.82% |
Earnings Summary
For their last quarter, Revolution Medicines (RVMD) reported earnings of -$0.70 per share, beating the Zacks Consensus Estimate of $-0.75 per share. This reflects a positive earnings surprise of 6.67%. Look out for RVMD's next earnings release expected on August 13, 2024. For the next earning release, we expect the company to report earnings of -$0.77 per share, reflecting a year-over-year increase of 16.3%.
Earnings History
Price & Consensus
Zacks News for RVMD
Sage Therapeutics, Inc. (SAGE) Reports Q1 Loss, Tops Revenue Estimates
RVMD: What are Zacks experts saying now?
Zacks Private Portfolio Services